Strainprint Guest Blog: 5 Lessons that Changed My Perspective on Cannabis

Recently, we came across this phenomenal blog: Flower & Freedom ( written by Bethany Rae. This blog post really resonated with us at Strainprint and we are compelled to share.

Have a read about Bethany’s medical cannabis journey and the invaluable information she’s learned, and is sharing, along the way:

5 Lessons that Changed My Perspective on Cannabis

Bethany Rae, Flower & Freedom Blog (

You are not alone if you’ve spent most of your adult life believing that cannabis is bad for you. I used to think cannabis was unhealthy, but it turns out it’s a lack of knowledge and education that is unhealthy. We have a lot to catch up on, having had cannabis research and science education restricted for the greater part of the 20th century. It’s time to take on the knowledge we need to be safe and educated consumers of cannabis. Cannabis was a healthy addition to my life once I took the time to understand the following lessons and apply them to my personal consumption.

Cannabinoids: How cannabis interacts in the human body
Did you know your body makes its own version of cannabis? Cannabinoids are the complex chemical compounds in cannabis that mimic naturally occurring compounds produced by our body, called endocannabinoids. There are many cannabinoids, the most famous being THC and CBD, and they bind to our receptor sites throughout our brain and body, modulating mood and feeling. Recent research has proposed that if your body is not performing optimally, it may be because of a lack of naturally-produced cannabinoids in your endocannabinoid system, resulting in cannabinoid deficiency.

Consumimg cannabis could help maintain cannabinoids at optimal levels, also known as homeostasis. Understanding how cannabis is interacting in your body is the first step to understanding how cannabis can be part of a healthy lifestyle.
THC vs CBD: Not all cannabis products will get you high
Want the benefits of cannabis without the high? Focusing on products lower in THC (tetrahydrocannabinol) and higher in CBD (cannabidiol) may provide the solution.

THC has the strongest psychoactive properties and CBD is non-psychoactive, providing pain relief and anti-anxiety effects. Although THC is proving to have many medical applications, including chronic pain relief, for those who are new to cannabis and are concerned about the euphoria and high, starting out with CBD products may be the ideal solution.

Terpenes: Aromas that drive the mood and feeling
Ever wondered about the difference between sativa, indica and hybrid? Turns out it’s the aromatic flavours in each strain, called terpenes, that make each strain unique. The combination of flavors, also known as the terpene profile, drive the mood and feeling of each strain. A sativa is usually more energetic because of the presence of the limonene terpene, a citrusy flavour also found in fruit.

An indica strain, more famous for relaxation and sleep, gets these effects from terpenes such as myrcene. A hybrid strain might have more of a balance of terpenes, but is likely dominant in one or more of the terpenes, leading it to be labelled sativa dominant or indica dominant. Some terpenes are known to assist with relief for certain disorders, such as caryophyllene for anxiety and linalool for depression, so getting to know your terpenes can make all the difference when selecting the right strain for you. Methods of Consumption: Different results for different intentions.

Consuming cannabis does not have to mean smoking a joint, pipe or bong. There are many different ways to experiment, depending on the desired effect and personal preference. Consuming cannabis can be a simple as applying a topical lotion or salve. The active compounds are absorbed through the skin in a targeted area for pain relief, without any psychoactive effects. Vaporizing cannabis gets quick results without the plant combustion caused by smoking. Oil drops provide an excellent alternative to inhalation. Placed under the tongue, they are quickly absorbed into the bloodstream. Capsules and precisely-labelled edibles take longer to come into effect, but for many people offer lasting pain relief.

Finding the method that best matches your intentions and desired effects is the key to enjoying your cannabis consumption.

Bethany Rae, Flower & Freedom Blog (

Microdosing: The smallest amount for the desired effects
Understanding that I could get the best results from the smallest amount possible, changed my relationship with cannabis. Microdosing is using a dose so low that it’s unlikely to produce whole-body effects, but high enough to allow the cellular response and benefits. My low tolerance to THC means that I can test and enjoy cannabis throughout my day, using tiny amounts and without getting too high. I look for products low in THC or I reduce the amount consumed as there are limited microdosing products on the market.

I might apply 2-3 drops of cannabis oil under the tongue, take one draw on my vaporizer or consume a low dose capsule to experiment with my optimal microdose level. See my post on Why I Microdose Cannabis for more.

Ultimately your experience is up to you, so I hope you take the time to learn and improve your cannabis experience. Focus first on your intentions. Are you hoping to improve your night’s sleep? Are you looking for some energy throughout the day? Using your cannabis 101 knowledge, you will be able to make better choices for your health and lifestyle. We’d love to hear about your experiences! Join us on Facebook for more interactions with Flower & Freedom.

Bethany Rae, Flower & Freedom Blog (

Strainprint Featured in High Canada Magazine

July 22, 2017 – Strainprint was recently featured in High Canada. Our story focused on innovation within the industry.

You can read more on the article (attached) or click on to the edition link directly (below). The Strainprint story on page 71.

Strainprint™ Technologies Ltd. (“Strainprint”) Announces The Formation of A World-Class Board of Medical Advisers

TORONTO, July 11, 2017 /PRNewswire/ – Strainprint™, the leader in cannabis data collection, is pleased to welcome Dr. Lyle Oberg, Dr. Sana-Ara Ahmed, and Dr. HJ Raza to its Board of Medical Advisors. Strainprint™ works closely with its medical advisors to support patients, enhance research and advance the scientific understanding of cannabinoid therapy.

Dr. Lyle Oberg began practicing medicine performing surgery, anesthesia, emergency medicine and obstetrics. Over 15 years, he has held senior Ministerial portfolios for the Province of Alberta, including Minister of Social Services, Minister of Learning, Minister of Infrastructure and Transportation and Minister of Finance. Dr. Oberg is a founder of Verde Health, a pioneer in virtual clinic management and tele-health software and is currently CEO of Flowco Holdings with interests in licensed cannabis production across North America.

Dr. Sana-Ara Ahmed is a specialist in anesthesiology & pain medicine in private practice in Alberta, Ontario and British Columbia. Dr. Ahmed is an expert in the use of medical cannabis for pain management in Canada taking a holistic approach to chronic pain management. She is an established CME educator for physicians and health professionals regarding medical cannabis use.

Dr. HJ Raza, is an internationally respected physician, researcher, educator and activist with an MD and Ph.D in neuroscience research from The Mount Sinai School of Medicine and board certification in Internal Medicine from The NYU Medical Center. Dr. Raza is a teaching attending on faculty at The Johns Hopkins School of Medicine where he leads research focused on neuroscience and the human endocannabinoid system.

Read More about Strainprint Advisors

“We are honoured to have three incredibly respected and passionate physicians join us to advance our platform. Their credibility and experience will be instrumental as we work to legitimatize cannabinoid therapy and shape public policy,” said Stephanie Karasick, Strainprint Founder and Chief Strategy Officer.

About Strainprint™:

Founded in Toronto in 2016, Strainprint™ Technologies Ltd. Strainprint manages the gathering and analysis of real-time cannabis consumption data and ranks specific strain efficacy against conditions and related symptoms. Strainprint™ data supports cannabis researchers globally and provides advanced intelligence to licensed producers to optimize grow operations and to clinics to improve treatment recommendations. For more information visit facebook, twitter, linkedin

Media Contact:
Jessica Moran
Strainprint Technologies Ltd.

Strainprint™ Technologies Ltd. Announces partnership with Emblem Cannabis corp. to create a licenced version of the Strainprint Medical Cannabis Research App

Toronto, Wednesday, June 28, 2017 – Strainprint Technologies Ltd. (“Strainprint”) — the leader in cannabis patient and strain efficacy data — is excited to announce the launch of the first ever co-branded version of its revolutionary mobile outcomes-tracking App with Emblem Cannabis Corp. (“Emblem”). This customized edition of the App features all the same great functionality but is enhanced with unique benefits for Emblem patients such as redeemable discounts on Emblem products.

Emblem will use data gathered by the App to better understand customer needs and to adapt production and service offerings accordingly. “Being the first Licensed Producer in Canada to work directly with Strainprint will give us a competitive understanding of real patient efficacy and allow us to meet the evolving needs of our patients, improving their quality of life,” said Maxim Zavet, President of Emblem Cannabis.

“It has been an absolute pleasure to work with the Emblem team, as they share our dedication of using research to improve patient care and increase quality of service,” said Evan Karasick, Chief Product Officer of Strainprint.

Strainprint now offers a turn-key, custom-branded version of its mobile App for licensed cannabis producers, clinics, researchers and government. This enables rapid community building through loyalty engagement and triggered messaging. Sandboxed patient data can be segregated by research requirements to run up to five unique clinical studies at once, which can be reported on independently. All Strainprint versions comply with HIPAA, PIPEDA and PHIPA privacy laws and all patient data remains completely confidential. Moreover, Strainprint can be seamlessly embedded or integrated with most electronic medical records (EMR) or seed2sale software providers.

The Strainprint mobile App is free for patients and is available for both iOS & Android from the Apple iTunes and Google Play Stores respectively. Emblem patients will receive a unique code to activate the additional premium features.

About StrainprintTM:
Founded in 2016, StrainprintTM Technologies Ltd. is a Toronto-based software company providing enterprise grade analytics and consumer solutions for the medical cannabis industry. Strainprint manages the gathering and analysis of real-time cannabis consumption data and ranks specific strain efficacy against conditions and related symptoms. Strainprint also works with commercial producers and clinics to provide advanced intelligence to optimize grow operations and advance treatment recommendations. For more information visit

About Emblem Corp.:
Emblem Cannabis Corp. is a fully integrated Canadian medical marijuana, healthcare and cannabinoid-based pharmaceutical company licensed to carry on business as a producer of medical cannabis by the Government of Canada.

Media Contacts:
Jessica Moran
Strainprint Technologies Ltd.

Ali Mahdavi
Director, Investor Relations
Emblem Corp.